Waters's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Waters in the second quarter 2026?
Waters Corporation achieved a return on average equity (ROE) of 1.88 % in its second quarter 2026, which is below Waters's average return on equity, which stands at 96.18%.

ROE decreased relative to the period ending , due to the decline in net income.

Within the Laboratory Analytical Instruments industry 6 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 1642 to 1655.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jul 04 2026) II. Quarter	(Apr 04 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 27 2025) III. Quarter	(Jun 28 2025) II. Quarter
Y / Y Equity Change	603.53 %	679.25 %	40.07 %	45.39 %	-
Y / Y Net Income Change	-	-	-1.74 %	-7.79 %	3.06 %
Net Income (TTM) in Millions	166	449	643	647	659
Return On Equity (TTM)	1.88 %	8.04 %	28.52 %	31.23 %	34.91 %
WAT's Total Ranking	# 1655	# 1642	# 278	# 167	# 230
Equity (TTM) in Millions	15,195	15,292	2,561	2,331	2,160
Seq. Equity Change	-0.63 %	497.05 %	9.89 %	7.91 %	10.06 %
Seq. Net Income Change	-	-	51.23 %	1.23 %	21.2 %

Back to WAT Management Effectiveness >> WAT's 5 Years Annual ROE >> Compare WAT ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 7
Sector	# 181
Overall	# 1655

Return On Equity Statistics
High	Average	Low
1827.86 %	96.18 %	0.83 %
(Mar 28 2020)		(Dec 31 2017)

WAT Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	2,561	1,829	1,150	504	368
Y / Y Equity Change	40.07 %	58.95 %	128.02 %	37.26 %	58.33 %
Net Income in Millions	643	638	642	708	693
Y / Y Net Income Change	0.75 %	-0.69 %	-9.26 %	2.15 %	32.84 %
Return On Equity	25.09 %	34.88 %	55.83 %	140.29 %	188.5 %

Back to WAT Management Effectiveness >> WAT's 5 Years Annual ROE >> Compare WAT ROE to its Competitors

Annual Roe Comment

In 2025 ROE fell to 25.09 %, despite net income growth.

More Return On Equity Ratios
Laboratory Analytical Instruments Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
WAT's' Return on Equity at Yahoo Finance
WAT's Roe Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for WAT's Competitors
Subscribers only: Roe for Waters's Suppliers
Subscribers only: Return On Equity for WAT's Customers

Companies with similar Return On Equity at Jul 04 2026, within Healthcare Sector	ROE
Pfizer Inc	4.91 %
Privia Health Group Inc	4.23 %
Becton Dickinson And Company	3.79 %
Alkermes Plc	3.72 %
Lifemd Inc	3.47 %
Lifestance Health Group Inc	3.39 %
Revvity Inc	3.27 %
Bio rad Laboratories Inc	3.15 %
Envista Holdings Corporation	3.08 %
Immucell Corporation	2.68 %
Surgery Partners Inc	2.63 %
Mimedx Group Inc	2.61 %
Cormedix Inc	2.18 %
Atricure Inc	2.14 %
Pacira Biosciences inc	2.13 %
Warby Parker Inc	2.06 %
Repligen Corp	1.98 %
Arvinas Inc	1.91 %
Waters Corporation	1.88 %
Omada Health Inc	1.84 %
Radnet Inc	1.42 %
Icu Medical Inc	1.41 %
Biomarin Pharmaceutical Inc	1.18 %
Staar Surgical Co	1.08 %
Champions Oncology Inc	0.94 %
Delcath Systems Inc	0.46 %

Date modified: 2026-09-26T07:09:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.